Latest Product News
Product News
DiaMedica Announces Positive Results from a Hypertension Study With its GSK3B-Blocking Antibody
DiaMedica announces antihypertensive results with antibody DM-204.
Product News
Helix BioPharma Files European Clinical Trial Application for a Phase I/II Study of its Lung Cancer Drug Candidate L-DOS47
L-DOS47 is intended to offer an innovative approach to the first-line treatment of inoperable, locally advanced, recurrent or metastatic, non-small cell lung cancer.
Product News
Immunotope and Immunovaccine Announce U.S. Patent for Therapeutic Cancer Vaccine Antigens
U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.
Product News
OGT Presents Prostate Cancer Data at the CHI Early Oncology Partnering Showcase and Tri-Con 2011
Oxford Gene Technology (OGT)is discussing recent developments in biomarker discovery at this year’s CHI International Molecular Medicine Tri-Conference (Tri-Con) in San Francisco, USA (23-25th February).
Product News
Lorus Therapeutics Announces Publication on LOR-2040 Anticancer Activity in Acute Myeloid Leukemia
Publication of a research article by OSU investigators demonstrate that LOR-2040, improves the anticancer effects of the chemotherapy drug Ara-C.
Product News
Lorus Therapeutics Announces Publication on LOR-2040 Anticancer Activity in Acute Myeloid Leukemia
Publication of a research article by OSU investigators demonstrate that LOR-2040, improves the anticancer effects of the chemotherapy drug Ara-C.
Product News
Taconic to Offer DuPont™ OncoMouse® Oncology Models for Use in Cancer Research
Company expands translational oncology research services by performing efficacy and compound profiling studies and making novel spontaneous tumor mouse models.
Product News
Sigma® Life Science Launches Oncology Disease Model Cell Lines
New tools for understanding biological pathways and accelerating drug development for personalized medicine.
Product News
Invivoscribe Announces Collaboration Agreement to Develop Companion Diagnostic Test
Test aims to identify FLT3 positive AML patients for specific use in connection with the Novartis development compound, midostaurin (PKC412).
Product News
PharmaGap Lead Drug to be Presented at American Association for Cancer Research 102nd Annual Meeting
Dr. Ken Sokoll, along with Dr. Barbara Vanderhyden presents results of testing of PharmaGap's lead cancer drug in two separate poster sessions in Orlando, Florida.
Advertisement
